Peripheral Stent Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage : by Product Type (Self-Expanding Stents, Balloon-Expandable Stents, Covered Stents, Drug-Eluting Stents, Bioresorbable Stents); Indication (Peripheral Artery Disease, Coronary Artery Disease, Renal Artery Disease, Carotid Artery Disease, Other Vascular Diseases); End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); and Geography (North America, Europe, Asia Pacific, and South and Central America)

The Peripheral Stent Market is expected to register a CAGR of 6.1% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report is segmented by Product Type (Analgesics, Cold & Cough Medications, Digestive Health Products, Vitamins & Dietary Supplements, Topical Products, Others). The market is further segmented based on by Distribution Channel (Pharmacies & Drugstores, Supermarkets & Hypermarkets, Online Pharmacies, Convenience Stores). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Peripheral Stent Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

• Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
• Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
• Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Peripheral Stent Market Segmentation

Product Type

• Self-Expanding Stents
• Balloon-Expandable Stents
• Covered Stents
• Drug-Eluting Stents
• Bioresorbable Stents

Indication

• Peripheral Artery Disease
• Coronary Artery Disease
• Renal Artery Disease
• Carotid Artery Disease
• Other Vascular Diseases

End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Peripheral Stent Market Growth Drivers

• Rising Prevalence of Cardiovascular Diseases: The increasing incidence of cardiovascular diseases such as coronary artery disease and peripheral artery disease is a major driver for the peripheral stent market. As these conditions require stenting procedures for vascular support and blood flow restoration, the demand for peripheral stents continues to grow, especially in aging populations with higher risk factors.
  
• Technological Advancements in Stent Design: Advances in stent technology, including drug-eluting stents (DES), bioresorbable stents, and improved materials, are propelling the growth of the peripheral stent market. These innovations improve patient outcomes, reduce the risk of restenosis, and enhance the long-term effectiveness of stents, driving their adoption in clinical practice.
  
• Growing Geriatric Population: The global aging population is contributing to the growing peripheral stent market. Older individuals are more susceptible to peripheral artery disease and other vascular disorders, increasing the need for stent interventions. This demographic trend creates a steady demand for peripheral stents, particularly in developed countries with aging populations.

Peripheral Stent Market Future Trends

• Shift Towards Minimally Invasive Procedures: There is a growing trend toward minimally invasive procedures, including the use of peripheral stents, due to their ability to reduce recovery time and complications. Patients and healthcare providers prefer these procedures over traditional open surgeries, fueling the demand for advanced peripheral stents.
  
• Use of Drug-Eluting Stents (DES): Drug-eluting stents are increasingly popular in the treatment of peripheral artery disease due to their ability to release medication that prevents restenosis. This trend toward DES is driven by their higher efficacy in reducing the risk of stent blockage and improving long-term patient outcomes.
  
• Rise of Biodegradable Stents: Biodegradable or bioresorbable stents are gaining traction in the peripheral stent market. These stents provide temporary vascular support and gradually dissolve after achieving their therapeutic effect, reducing long-term complications and eliminating the need for further surgical interventions, a trend that is changing the landscape of stent technology.

Peripheral Stent Market Opportunities

• Expansion in Emerging Markets: Emerging markets, particularly in Asia-Pacific, Latin America, and Africa, offer significant growth opportunities for the peripheral stent market. Increased healthcare access, improving medical infrastructures, and rising cardiovascular disease rates in these regions drive the demand for peripheral stents, creating new revenue streams for global manufacturers.
  
• Innovation in Stent Materials: There is a growing opportunity for developing new stent materials, such as flexible alloys, polymers, and composites, that can enhance the performance and reduce complications associated with stents. Manufacturers can capitalize on this opportunity by investing in R&D to create superior stents with better biocompatibility, reduced thrombosis, and fewer adverse reactions.
  
• Integration with Advanced Imaging Technologies: The integration of peripheral stents with advanced imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), provides an opportunity for more accurate placement and monitoring of stents. This collaboration offers potential for improved patient outcomes and precision, driving the adoption of stents in clinical practice.

Peripheral Stent Market Regional Insights

The regional trends and factors influencing the Peripheral Stent Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Peripheral Stent Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Peripheral Stent Market Report Scope

Peripheral Stent Market Players Density: Understanding Its Impact on Business Dynamics

The Peripheral Stent Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Peripheral Stent Market are:

1. Medtronic plc
2. Abbott Laboratories
3. Boston Scientific Corporation
4. Cordis (A Cardinal Health Company)
5. Cook Medical
6. Terumo Corporation

Disclaimer: The companies listed above are not ranked in any particular order.

Key Selling Points

• Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Peripheral Stent Market, providing a holistic landscape.
• Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
• Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
• Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Peripheral Stent Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

• Medtronic plc


• Abbott Laboratories


• Boston Scientific Corporation


• Cordis (A Cardinal Health Company)


• Cook Medical


• Terumo Corporation


• B. Braun Melsungen AG


• Johnson & Johnson


• Sorin Group (now LivaNova)


• Cardiovascular Systems, Inc